Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,188.95
+33.95 (0.66%)
At close: Sep 16, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 617.07 billion as of September 16, 2026. Its market cap has decreased by -6.17% in one year.
Market Cap
617.07B
Enterprise Value
602.22B
Revenue
150.81B
Ranking
n/a
PE Ratio
28.60
Stock Price
5,188.95
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 617.07B, an increase of 273.53%. That is a compound annual growth rate of 13.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 617.07B | -6.27% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.84T |
| Dr. Reddy's Laboratories | 957.72B |
| Lupin | 939.78B |
| Abbott India | 555.53B |
| GlaxoSmithKline Pharmaceuticals | 476.73B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 216.20B |
| Caplin Point Laboratories | 195.41B |